Technology M&A Advisory

M&A Advisory

Lazard

Full Credential Description

ArQule. United States. Announced Date 20/01/2011. Closed Date 25/01/2011. Deal value: $50m. Underwritten registered direct offering of common stock. Industry: ArQule is a biotechnology company focused on developing targeted therapies for the treatment of cancer.

Back to Search Contact Business